Director of Clinical Pharmacology - Early Development

BioSpace; Indianapolis (IN); On-site; USD 177,000 - 339,000; Full time

Job summary

Lilly seeks a Clinical Research Scientist (CRS) with expertise in early clinical development, including clinical pharmacology, to advance multiple assets into first‑in‑human studies and support biomarker‑driven programs.

The CRS will shape global trial designs, ensure compliance with GCP/regulatory requirements, and partner with cross‑functional teams to deliver science‑driven, patient‑focused medicines. Strong communication and international collaboration are essential.

Qualifications

• Advanced health/medical/scientific graduate degree or related graduate degree (e.g., PharmD, PhD, MSN).
• 3 years of pharmaceutical industry experience or similar.
• 3 years of clinical practice experience.
• Fluent in English (written and spoken).
• Strong communication, interpersonal and organizational skills.
• Willingness to travel domestically and internationally.

Responsibilities

• Develop clinical pharmacology plans and diseases for early assets.
• Design and oversee phase 1/2 studies and biomarker plans.
• Collaborate across functions for regulatory submissions and safety reviews.
• Provide oversight of protocol development, risk assessment, and data interpretation.
• Coordinate with global teams on publication and regulatory documentation.

Skills

Clinical pharmacology

Pharmaceutical industry experience

Communication skills

Regulatory knowledge

Travel readiness

Education

Advanced health/medical/scientific graduate degree

Job description

Lilly seeks a Clinical Research Scientist (CRS) with expertise in early clinical development, including clinical pharmacology, to advance multiple assets into first‑in‑human studies and support biomarker‑driven programs.

The CRS will shape global trial designs, ensure compliance with GCP/regulatory requirements, and partner with cross‑functional teams to deliver science‑driven, patient‑focused medicines. Strong communication and international collaboration are essential.